Article
Outcomes in Lower-Risk MDS Advance As Novel Strategies Emerge
Rating:
0.0
Views:
101
Likes:
1
Library:
1
Outcomes for patients with myelodysplastic syndrome range from a median of 5.3 years in the lower-risk population to 8.4 months among patient with very high-risk disease. These outcomes are changing as novel therapies for the lower-risk population enter the treatment landscape.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value